These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38223482)

  • 21. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.
    Ogawa C; Tsuchiya K; Tomosugi N; Kanda F; Maeda K; Maeda T
    PLoS One; 2017; 12(6):e0179608. PubMed ID: 28662118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.
    Cui R; Gale RP; Zhu G; Xu Z; Qin T; Zhang Y; Huang G; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
    Leuk Res; 2014 May; 38(5):545-50. PubMed ID: 24598841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum transferrin receptor as a marker of erythropoiesis suppression in patients on chronic transfusion.
    Tancabelic J; Sheth S; Paik M; Piomelli S
    Am J Hematol; 1999 Feb; 60(2):121-5. PubMed ID: 9929103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
    Breymann C; Fibach E; Visca E; Huettner C; Huch A; Huch R
    J Matern Fetal Med; 1999; 8(1):1-7. PubMed ID: 10052837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoiesis and Iron Parameters in Transfusion-dependent and Nontransfusion-dependent Thalassemias.
    Ozturk Z; Gumuslu S; Yalcin K; Kupesiz A
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):186-192. PubMed ID: 34157011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary hepcidin in congenital chronic anemias.
    Kearney SL; Nemeth E; Neufeld EJ; Thapa D; Ganz T; Weinstein DA; Cunningham MJ
    Pediatr Blood Cancer; 2007 Jan; 48(1):57-63. PubMed ID: 16220548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markers of ineffective erythropoiesis in non-transfusion dependent β-thalassaemia.
    Khairullah S; Jackson N
    Med J Malaysia; 2021 Jan; 76(1):41-45. PubMed ID: 33510107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Exogenous Transferrin on the Regulation of Iron Metabolism and Erythropoiesis in Iron Deficiency With or Without Anemia.
    Li Y; Miller I; Prasad P; George NA; Parrow NL; Fleming RE
    Front Physiol; 2022; 13():893149. PubMed ID: 35634155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal hemochromatosis with εγδβ-thalassemia: a case report and analysis of serum iron regulators.
    Tsuge M; Kodera A; Sumitomo H; Araki T; Yoshida R; Yasui K; Sato H; Washio Y; Washio K; Shigehara K; Yashiro M; Yagi T; Tsukahara H
    BMC Pediatr; 2022 Oct; 22(1):622. PubMed ID: 36309641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
    Cazzola M; Ponchio L; de Benedetti F; Ravelli A; Rosti V; Beguin Y; Invernizzi R; Barosi G; Martini A
    Blood; 1996 Jun; 87(11):4824-30. PubMed ID: 8639855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minihepcidins improve ineffective erythropoiesis and splenomegaly in a new mouse model of adult β-thalassemia major.
    Casu C; Chessa R; Liu A; Gupta R; Drakesmith H; Fleming R; Ginzburg YZ; MacDonald B; Rivella S
    Haematologica; 2020 Jul; 105(7):1835-1844. PubMed ID: 31582543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic Resonance Imaging Quantification of the Liver Iron Burden and Volume Changes Following Treatment With Thalidomide in Patients With Transfusion-Dependent
    Che J; Luo T; Huang L; Lu Q; Yan D; Meng Y; Xie J; Chen W; Chen J; Long L
    Front Pharmacol; 2022; 13():810668. PubMed ID: 35250561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients.
    Galanello R; Barella S; Turco MP; Giagu N; Cao A; Dore F; Liberato NL; Guarnone R; Barosi G
    Blood; 1994 Jan; 83(2):561-5. PubMed ID: 7506955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats.
    Theurl M; Nairz M; Schroll A; Sonnweber T; Asshoff M; Haschka D; Seifert M; Willenbacher W; Wilflingseder D; Posch W; Murphy AT; Witcher DR; Theurl I; Weiss G
    Haematologica; 2014 Sep; 99(9):1516-24. PubMed ID: 24895335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized placebo-controlled clinical trial of oral green tea epigallocatechin 3-gallate on erythropoiesis and oxidative stress in transfusion-dependent β-thalassemia patients.
    Settakorn K; Hantrakool S; Petiwathayakorn T; Hutachok N; Tantiworawit A; Charoenkwan P; Chalortham N; Chompupoung A; Paradee N; Koonyosying P; Srichairatanakool S
    Front Mol Biosci; 2023; 10():1248742. PubMed ID: 38328786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study.
    Ali Z; Ismail M; Rehman IU; Rani GF; Ali M; Khan MTM
    Sci Rep; 2023 Aug; 13(1):13592. PubMed ID: 37604857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutual Cross Talk Between Iron Homeostasis and Erythropoiesis.
    Rybinska I; Cairo G
    Vitam Horm; 2017; 105():143-160. PubMed ID: 28629515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
    Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
    Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis.
    Cazzola M; Borgna-Pignatti C; Locatelli F; Ponchio L; Beguin Y; De Stefano P
    Transfusion; 1997 Feb; 37(2):135-40. PubMed ID: 9051086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.